KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardant Health (GH) Interest & Investment Income (2017 - 2026)

Guardant Health's Interest & Investment Income history spans 9 years, with the latest figure at $10.0 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 13.91% to $10.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.1 million, a 36.5% decrease, with the full-year FY2025 number at $34.1 million, down 36.5% from a year prior.
  • Interest & Investment Income hit $10.0 million in Q4 2025 for Guardant Health, up from $7.4 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for GH hit a ceiling of $14.9 million in Q1 2024 and a floor of $653000.0 in Q4 2021.
  • Historically, Interest & Investment Income has averaged $6.7 million across 5 years, with a median of $7.1 million in 2023.
  • Biggest five-year swings in Interest & Investment Income: plummeted 70.21% in 2021 and later surged 566.48% in 2023.
  • Tracing GH's Interest & Investment Income over 5 years: stood at $653000.0 in 2021, then skyrocketed by 229.25% to $2.2 million in 2022, then skyrocketed by 545.95% to $13.9 million in 2023, then fell by 16.09% to $11.7 million in 2024, then dropped by 13.91% to $10.0 million in 2025.
  • Business Quant data shows Interest & Investment Income for GH at $10.0 million in Q4 2025, $7.4 million in Q3 2025, and $7.6 million in Q2 2025.